Core Viewpoint - The announcement details the completion of the non-public issuance of exchangeable bonds by the controlling shareholder, Beijing Harmony Hengyuan Technology Co., Ltd., with a total fundraising scale of up to RMB 600 million, divided into two varieties of bonds [1][2]. Group 1: Bond Issuance Details - The bonds have a maximum term of three years and are categorized into two types: Type One with a maximum issuance scale of RMB 400 million and Type Two with a maximum issuance scale of RMB 200 million [1]. - The controlling shareholder plans to deposit 50 million shares of the company into a dedicated securities account for the exchangeable bonds, which includes the interest generated during the trust period [2]. Group 2: Share Pledge and Trust Registration - Of the 50 million shares, 33 million shares will be placed in the "Harmony Hengyuan - Hongta Securities - 25 Harmony E1 Trust Property Special Account," and 17 million shares in the "Harmony Hengyuan - Hongta Securities - 25 Harmony E2 Trust Property Special Account" [2]. - The shares will be managed by Hongta Securities as the nominal holder to provide guarantees for the bondholders regarding the exchange of shares and repayment of the bond principal and interest [2][3]. Group 3: Other Relevant Information - The pledge and trust registration will not lead to a change in the actual control of the company, and the voting rights of the pledged shares will be exercised based on the opinions of Harmony Hengyuan, ensuring the interests of the bondholders are not harmed [3].

证券代码：000935 证券简称：四川双马 公告编号：2025-37 四川和谐双马股份有限公司 关于控股股东非公开发行可交换公司债券办理完成 部分股份担保及信托登记的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚 假记载、误导性陈述或重大遗漏。 2025年8月12日，四川和谐双马股份有限公司（简称"公司"）在巨潮资讯 网（www.cninfo.com.cn）披露了《关于控股股东非公开发行可交换公司债券拟 办理部分股份担保及信托登记的公告》（公告编号：2025-36）。公司控股股东 北京和谐恒源科技有限公司（简称"和谐恒源"）拟发行期限为不超过3年（含）， 募集资金规模不超过人民币6亿元（含）的可交换公司债券。本期债券分为二个 品种，债券名称分别为北京和谐恒源科技有限公司2025年面向专业投资者非公开 发行可交换公司债券（第一期）（品种一）、北京和谐恒源科技有限公司2025 年面向专业投资者非公开发行可交换公司债券（第一期）（品种二），其中品种 一发行规模不超过4亿元（含），品种二发行规模不超过2亿元（含）。 和谐恒源拟将其持有的公司无限售条件的流通股5000万股股份（包括登记在 担保及 ...

Group 1 - The diversified financial sector increased by 0.38% on August 14, with Nanhua Futures leading the gains [1] - The Shanghai Composite Index closed at 3666.44, down 0.46%, while the Shenzhen Component Index closed at 11451.43, down 0.87% [1] - Key stocks in the diversified financial sector showed varied performance, with Nanhua Futures rising by 6.52% to a closing price of 24.52 [1] Group 2 - Major stocks that declined included Jiuding Investment, which fell by 9.98% to a closing price of 19.48 [2] - The overall net capital flow in the diversified financial sector showed a net inflow of 49.12 million yuan from main funds, while retail investors contributed a net inflow of 15.2 million yuan [2] - The trading volume and turnover for various stocks in the sector varied significantly, with Lakala achieving a turnover of 3.774 billion yuan [1][2]

Group 1 - The stock price of Sichuan Shuangma closed at 19.59 yuan on August 12, 2025, down 1.80% from the previous trading day [1] - The trading volume on that day was 109,418 lots, with a total transaction amount of 215 million yuan [1] - Sichuan Shuangma's main business includes cement manufacturing and pharmaceutical health sectors [1] Group 2 - The company has established 10 production lines for peptide active pharmaceutical ingredients at its Hubei Jianxiang base, compliant with EU and FDA standards [1] - An A16 workshop is currently under construction, which is expected to significantly enhance production capacity once completed [1] Group 3 - On August 12, the net outflow of main funds was 18.76 million yuan, with a cumulative net outflow of 51.14 million yuan over the past five days [1]

Group 1 - The company Sichuan Shuangma (000935.SZ) has confirmed that its raw material drug production base, Hubei Jianxiang, has completed 10 production lines for peptide raw materials that meet EU and FDA standards [1] - The construction of the A16 workshop at Hubei Jianxiang is currently underway, and once completed, it will significantly enhance production capacity [1]

关于控股股东非公开发行可交换公司债券拟办理 部分股份担保及信托登记的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚 假记载、误导性陈述或重大遗漏。 四川和谐双马股份有限公司(简称"公司"或"本公司"）于近日接到控股 股东北京和谐恒源科技有限公司（简称"和谐恒源"）的告知函，和谐恒源拟以 其持有的部分本公司股票为标的面向专业投资者非公开发行可交换公司债券（第 一期）并已取得深圳证券交易所（简称"深交所"）出具的《关于北京和谐恒源 科技有限公司非公开发行可交换公司债券符合深交所挂牌条件的无异议函》（深 证函〔2025〕730号）。和谐恒源拟发行期限为不超过3年（含），募集资金规模 不超过人民币6亿元（含）的可交换公司债券。本期债券分为二个品种，债券名 称分别为北京和谐恒源科技有限公司2025年面向专业投资者非公开发行可交换 公司债券（第一期）（品种一）、北京和谐恒源科技有限公司2025年面向专业投 资者非公开发行可交换公司债券（第一期）（品种二），其中品种一发行规模不 超过4亿元（含），品种二发行规模不超过2亿元（含）。 证券代码：000935 证券简称：四川双马 公告编号：2025-36 ...

Core Viewpoint - Sichuan Shuangma is actively involved in the pharmaceutical sector through direct investments and participation in funds, focusing on biopharmaceuticals and innovative technologies [1] Group 1: Direct Investments - The company’s direct investment primarily targets biopharmaceutical research and production enterprises, specifically Shenzhen Jianyuan, which specializes in the development and production of peptide raw materials and contract development and manufacturing (CDMO) [1] - Shenzhen Jianyuan also engages in the research and production of beauty peptides, indicating a diverse product range within the biopharmaceutical sector [1] Group 2: Fund Participation - Sichuan Shuangma participates in the Shanghai Hexie Huizi Fund, which adopts a venture capital strategy aimed at investing in cutting-edge technology innovation companies, particularly in new drug development and biotechnology [1] - The focus on biopharmaceutical funds highlights the company's commitment to advancing in the pharmaceutical industry through strategic investments [1]

Group 1 - The core point of the article is the strategic cooperation between Hanyu Pharmaceutical and the digital asset platform KuCoin to explore the tokenization of "future revenue rights of innovative drug research and development" as a pilot project in Hong Kong [1] - The company is actively exploring innovative models based on its operational needs and appreciates suggestions regarding potential collaborations with major shareholders and other digital asset platforms [1]

Group 1 - The stock price of Sichuan Shuangma closed at 19.33 yuan on August 4, 2025, with a slight decrease of 0.02 yuan, representing a drop of 0.10% [1] - The company reported a trading volume of 1.58 billion yuan, with a fluctuation of 1.91% and a turnover rate of 1.08% on the same day [1] - Sichuan Shuangma's main business includes cement and building materials, while also venturing into biotechnology and medical aesthetics [1] Group 2 - The company aims to continuously promote the development of its core business and focus on high-growth industries such as biotechnology [1] - Sichuan Shuangma is seeking synergistic business opportunities to enhance its long-term competitiveness [1] - In investor interactions, the company expressed its commitment to optimizing its business layout and enhancing investor confidence through performance growth and development prospects [1] Group 3 - On August 4, the net inflow of main funds was 3.6693 million yuan, with a cumulative net inflow of 22.8371 million yuan over the past five days [1]

证券之星消息，8月1日多元金融板块较上一交易日下跌0.02%，南华期货领跌。当日上证指数报收于 3559.95，下跌0.37%。深证成指报收于10991.32，下跌0.17%。多元金融板块个股涨跌见下表： | 代码 | 名称 | 收盘价 | 涨跌幅 | 成交量(手) | 成交额(元) | | --- | --- | --- | --- | --- | --- | | 600830 | 普流融通 | 11.47 | 6.01% | 54.37万 | 6.21亿 | | 600053 | 九鼎投资 | 16.31 | 2.00% | 9.26万 | 1.50亿 | | 000617 | 中油资本 | 8.77 | 1.27% | 299.70万 | 26.42 亿 | | 000532 | 华金资本 | 15.33 | 0.92% | 8.37万 | 1.28亿 | | 600318 | 新力金融 | 9.84 | 0.72% | 24.09万 | 2.37亿 | | 600120 | 浙江东方 | 6.08 | 0.66% | 41.97万 | 2.54亿 | | 000987 | 越秀资本 | 7.39 | ...